Differentiation of basal insulins in randomized clinical trials in T2DM subjects: a model-based meta-analysis of HbA1c and hypoglycemic event rates

被引：0
|
作者：
Vaddady, Pavan [1 ]
Lovern, Mark [2 ]
Lommerse, Jos [2 ]
Fancourt, Craig [1 ]
Kandala, Bhargava [1 ]
Mandema, Jaap [2 ]
Gheyas, Ferdous [1 ]
Kerbusch, Thomas [2 ]
Visser, Sandra A. G. [1 ]
机构：
[1] Merck & Co Inc, Kenilworth, NJ USA
[2] Certara Strateg Consultancy, Kenilworth, NJ USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
T-032
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [21] Factors associated with HbA1c reduction in Asian patients with T2DM: an analysis of the FINE Asia registry
    Kiat, K. Tan Eng
    Ji, L.
    Suastika, K.
    Wang, J.
    Wang, E.
    Lin, J.
    Tsai, S. -T.
    DIABETOLOGIA, 2011, 54 : S428 - S428
  • [22] Relationship of baseline HbA1c, HbA1c change and HbA1c target of < 7% with insulin analogues in type 2 diabetes: a meta-analysis of randomised controlled trials
    Giugliano, D.
    Maiorino, M.
    Bellastella, G.
    Chiodini, P.
    Esposito, K.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (05) : 602 - 612
  • [23] Effect of non-surgical periodontal treatment on HbA1c: a meta-analysis of randomized controlled trials
    Liew, A. K. C.
    Punnanithinont, N.
    Lee, Y-C
    Yang, J.
    AUSTRALIAN DENTAL JOURNAL, 2013, 58 (03) : 350 - 357
  • [24] Effect of pitavastatin on glucose, HbA1c and incident diabetes: A meta-analysis of randomized controlled clinical trials in individuals without diabetes
    Vallejo-Vaz, Antonio J.
    Seshasai, Sreenivasa Rao Kondapally
    Kurogi, Kazumasa
    Michishita, Ichiro
    Nozue, Tsuyoshi
    Sugiyama, Seigo
    Tsimikas, Sotirios
    Yoshida, Hiroshi
    Ray, Kausik K.
    ATHEROSCLEROSIS, 2015, 241 (02) : 409 - 418
  • [25] Factors associated with the effect-size of thiazolidinedione (TZD) therapy on HbA1c:: a meta-analysis of published randomized clinical trials
    Phatak, Hemant M.
    Yin, Donald D.
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (11) : 2267 - 2278
  • [26] Renshen (Panax ginseng) and Huanglian (Rhizoma Coptidis) For T2DM A protocol of systematic review and meta-analysis of randomized clinical trials
    Wang, Shengnan
    Yue, Rensong
    Huang, Xiaoying
    Li, Linzhi
    Xu, Chenyi
    Liu, Longyan
    MEDICINE, 2021, 100 (02) : E23743
  • [27] Hypoglycemia as a Function of HbA1c in Type 2 Diabetes (T2DM): Insulin Glargine 300 U/mL in a Patient-Level Meta-analysis of EDITION 1, 2, and 3
    Bonadonna, Riccardo C.
    Yale, Jean-Francois
    Brulle-Wohlhueter, Claire
    Corfec, Emmanuelle Boelle-Le
    Choudhary, Pratik
    Bailey, Timothy S.
    DIABETES, 2016, 65 : A239 - A239
  • [28] Basal insulin plus GLP-1 RA or SGLT2 inhibitor was noninferior to basal-bolus insulin intensification for HbA1c in T2DM
    Boggild, Miranda K.
    Cheung, Angela M.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (09) : JC106 - JC106
  • [29] Efficacy and safety of dorzagliatin, a novel glucokinase activators, in the treatment of T2DM: A meta-analysis of randomized controlled trials
    Wu, Yuqian
    Wang, Kai
    Su, Jingyang
    Liu, Xin
    MEDICINE, 2024, 103 (08) : E36916
  • [30] MODEL-BASED META-ANALYSIS (MBMA) OF THE HbA1c LOWERING EFFECT OF SGLT-2 INHIBITORS (SGLT2i): IMPACT OF BASELINE HbA1c, RENAL FUNCTION AND BACKGROUND TREATMENT.
    Mandema, J.
    Terra, S.
    Sweeney, K.
    Sahasrabudhe, V.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S33 - S33
12345